U.S. Crispr-Based Gene Editing Market Size & Outlook

Name: U.S. Crispr-Based Gene Editing Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The crispr-based gene editing market in the United States is expected to reach a projected revenue of US$ 5,173.1 million by 2033. A compound annual growth rate of 15.1% is expected of the United States crispr-based gene editing market from 2026 to 2033.

Biotechnology
- Genomics & Genetic Engineering
  - CRISPR-based Gene Editing Market Outlook

U.S. crispr-based gene editing type outlook (Revenue, USD million, 2021-2033)
- Product
  - CRISPR Kits & Reagents
  - CRISPR Libraries
  - Others
- Service
U.S. crispr-based gene editing application outlook (Revenue, USD million, 2021-2033)
- Biomedical
  - Therapeutic Development
    - Genetic Disorders
    - Oncology
    - Ophthalmology
    - Others
  - Disease Diagnostics
- Agricultural Applications
  - Plant Engineering
  - Farm Animals Engineering
  - Others
U.S. crispr-based gene editing end use outlook (Revenue, USD million, 2021-2033)
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations

U.S. Crispr-Based Gene Editing Market Size & Outlook

Data Tree

Sign up - it's easy, and free!